Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Stem Cells. 2010 Sep;28(9):1560-7. doi: 10.1002/stem.491.
B-cell regulator of immunoglobulin heavy chain transcription (Bright)/ARID3a, an A+T-rich interaction domain protein, was originally discovered in B lymphocyte lineage cells. However, expression patterns and high lethality levels in knockout mice suggested that it had additional functions. Three independent lines of evidence show that functional inhibition of Bright results in increased developmental plasticity. Bright-deficient cells from two mouse models expressed a number of pluripotency-associated gene products, expanded indefinitely, and spontaneously differentiated into cells of multiple lineages. Furthermore, direct knockdown of human Bright resulted in colonies capable of expressing multiple lineage markers. These data suggest that repression of this single molecule confers adult somatic cells with new developmental options.
B 细胞免疫球蛋白重链转录调控因子(Bright)/富含 A+T 的相互作用域蛋白(ARID3a)最初在 B 淋巴细胞系细胞中被发现。然而,在 knockout 小鼠中的表达模式和高致死率表明它具有其他功能。有三条独立的证据表明,Bright 的功能抑制会导致发育可塑性增加。来自两种小鼠模型的 Bright 缺陷细胞表达了许多多能性相关基因产物,无限扩增,并自发分化为多种谱系的细胞。此外,直接敲低人 Bright 导致能够表达多种谱系标记物的集落。这些数据表明,抑制这个单一分子赋予了成年体细胞新的发育选择。